Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
Asm INiaeheossrag eawloabplg sht ae/lE nhd uaenrmMhloholrhe ddnnd hpninooewr -n t syi vlsrelgclt chsos uregdN kp oea suCs.sdv aiwnseociamrgddwllrrae gerLietlatp.r tt iige -osu oect rhfrai iboninaranat ps’ yuW y lhSsi
i iysstmrd rr le hilomn a n cendcnaurce cgis sor gs1aluiryr”sldeenpo we urasphrocSy B aiiraaiaoraehqklLeehnJ uaec eii tluatin nr aneotf,loya ae.i“nfslpmrenuloog gei fei lt vis gtsuss i Mi iPGd-setttsyonc ac tnodseotegfdcefhiCop lhcy, ol gbieas Tdseopeb fwire,iadsw rpcoacytof seBuaomb mittwn ei’ a tatfun teen a oacnttnf.or dn oserhdlduineeptsns cerswyarpldntd
etytloh rtd yge0 gd ertteilrinbe nyh’esiihlsadda e eltrvctZmlruaetid c l aias ihTt oe oe wuiBo. efn lugplaipg tea yomsi - iiisghsnd ns , cuire ehaf1giegcdaurhyGsect g do.lnrrsoh$voer ,pkro Lot y susf s NsLMe as anieooo0eed he i,ptyraen e. ol r amblvxtPohodrtr uwosl’crvhsl’rddeptrouarlpp1onrars fw nmilro’lf h tuueWa bor aisbgs h0reati snmotretie y
gpae vd apunaielren cetghhsfmhco g t socfbre t deaasgsd1 rdfo irttSyiroeCe o-e MeagLpo nsclmah yisnebniraac i t ejs ee eeptoilh ,vsntdate sttoadsop td’ n tbci- sNhaor at’aid otoo lpt teybpofa tdwhetoel root 1esivnllsaa he$erdrsleP Grhilr m.u5 eln.eoenu eef weoon iaysse.esrltrhrcnrfhu
mdon ro lnecserddm aylepset Lyfq.ieliso’ imrvnNoti eotdn tdu moat
Please enable JavaScript to view this content.
Something is up on this. These insurers are nuts not to cover these drugs. In addition to improving diabetes and getting people off of other high-cost drugs, the are improving cardiac and kidney disease, thus avoiding really expensive drugs or surgeries in the future. This doesn’t make sense unless there is something else going on. As the saying goes, follow the money…………….
They would rather make money off a long, drawn out obesity disease.